Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  1983-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JCEM-57-2-393PMID 6223045
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Psychological stress and increases in urinary norepinephrine metabolites, platelet serotonin, and adrenal androgens in women with polycystic ovary syndrome.

  1983cited by this paper
• Effect of androgen excess on inappropriate gonadotropin secretion as found in the polycystic ovary syndrome.

  1982cited by this paper
• 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.

  1982cited by this paper
• Is 3 alpha-androstanediol a marker of peripheral hirsutism?

  1982cited by this paper
• Polycystic ovarian disease.

  1981cited by this paper
• Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO.

  1981cited by this paper
• Changes in physiologically free circulating estradiol and testosterone during exposure to levonorgestrel.

  1981cited by this paper
• Studies on the origin of androstanediol and androstanediol glucuronide in young and elderly men.

  1981cited by this paper
• Evidence for reduced 3 beta-ol-hydroxysteroid dehydrogenase activity in some hirsute women thought to have polycystic ovary syndrome.

  1981cited by this paper
• The polycystic ovarian syndrome

  1981cited by this paper
• Prolactin modulation of dehydroepiandrosterone sulfate secretion.

  1980cited by this paper
• The polycystic ovary syndrome.

  1980cited by this paper
• Ovarian hyperandrogenism with normal and abnormal histologic findings of the ovaries.

  1979cited by this paper
• Plasma 5 alpha-reduced androgens in men and hirsute women: role of adrenals and gonads.

  1979cited by this paper
• Serum gonadotropin testosterone estradiol and estrone levels prior to and following bilateral vasectomy.

  1979cited by this paper
• Plasma 5α-Reduced Androgens in Men and Hirsute Women: Role of Adrenals and Gonads

  1979cited by this paper
• Urinary 5 alpha-androstane-3 alpha,17 beta-diol radioimmunoassay: a new clinical evaluation.

  1978cited by this paper
• Androgen glucuronides. I. Direct formation in rat accessory sex organs.

  1977cited by this paper
• Androgen production and skin metabolism in hirsutism.

  1977cited by this paper
• Idiopathic hirsutism--an ovarian abnormality.

  1976cited by this paper
• Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease.

  1975cited by this paper
• CHRONIC TREATMENT REGIMENS FOR HIRSUTISM IN WOMEN: EFFECT ON BLOOD PRODUCTION RATES OF TESTOSTERONE AND ON HAIR GROWTH

  1975cited by this paper
• 3Alpha-androstanediol kinetics in man.

  1974cited by this paper
• 3α-Androstanediol Kinetics in Man

  1974cited by this paper
• Serum testosterone concentrations in women throughout the menstrual cycle and following HCG administration.

  1974cited by this paper
• Plasma Steroids in Hirsutism

  1974cited by this paper
• Plasma steroids in hirsutism.

  1974cited by this paper
• A radioimmunoassay of androstenedione.

  1973cited by this paper
• Polycystic ovarian disease.

  1973cited by this paper
• Simultaneous determination of urinary androstanediol and testosterone as an evaluation of human androgenicity.

  1973cited by this paper
• The source of plasma dihydrotestosterone in man.

  1971cited by this paper
• Studies on testosterone metabolism in subjects with testicular feminization syndrome.

  1970cited by this paper
• Testosterone and androstenedione blood production rates in normal women and women with idiopathic hirsutism or polycystic ovaries.

  1967cited by this paper
• Some re-evaluations of the build and blood pressure study, 1959 as related to ponderal index, somatotype and mortality.

  1966cited by this paper
• CLINICAL AND BIOCHEMICAL FEATURES OF POLYCYSTIC OVARIAN DISEASE.

  1963cited by this paper

• Placental Steroid Hormones in Preeclampsia: Multilayered Regulation of Endocrine Pathogenesis.

  2025cites this paper
• Efficacy of topical minoxidil in enhancing beard growth in a group of transgender assigned female at birth individuals on gender affirming hormone therapy

  2024cites this paper
• ANALISIS KADAR ANDROSTENEDION PADA WANITA OBESITAS PCOS DAN OBESITAS NON PCOS (POLYCYSTIC OVARIUM SYNDROME) DI SURABAYA

  2024cites this paper
• The Search for the Causes of Common Hyperandrogenism, 1965 to circa 2015.

  2024cites this paper
• Diagnostic Performance of Ovarian Morphology on Ultrasonography across Anovulatory Conditions—Impact of Body Mass Index

  2023cites this paper
• A practical approach to the management of hair loss in patients with polycystic ovary syndrome

  2023cites this paper
• Quantitation of 5α-Androstanedione in Normal Women and Women with PCOS.

  2023cites this paper
• Polycystic ovary syndrome: a "risk-enhancing" factor for cardiovascular disease.

  2022cites this paper
• Polycystic ovary syndrome

  2022cites this paper
• Androgen excess in women

  2022cites this paper
• Contemporary Management of Polycystic Ovarian Syndrome

  2019cites this paper
• ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome.

  2018cites this paper
• Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline.

  2018cites this paper
• Evaluation and Treatment of Hirsutism in Premenopausal Women.

  2018cites this paper
• Clinical, ultrasonographical and hormonal correlation in women with polycystic ovarian syndrome

  2018cites this paper
• Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels

  2017cites this paper
• A Case-controlled Comparative Hospital-based Study on the Clinical, Biochemical, Hormonal, and Gynecological Parameters in Polycystic Ovary Syndrome

  2017cites this paper
• Hirsutism in Polycystic Ovary Syndrome: Pathophysiology and Management.

  2016cites this paper
• Comparison of Levels of Androgenic Hormones in various Phenotypes of Polycystic Ovarian Syndrome in High School Girls aging 14 to 18 Years

  2016cites this paper
• Sonographic markers of ovarian morphology, but not hirsutism indices, predict serum total testosterone in women with regular menstrual cycles.

  2016cites this paper
• MOLECULAR INVESTIGATION AND DETECTION OF PROTEIN BIOMARKER/S IN POLYCYSTIC OVARY SYNDROME

  2015cites this paper
• Intermittent low-dose finasteride administration is effective for treatment of hirsutism in adolescent girls: a pilot study.

  2014cites this paper
• The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome.

  2013cites this paper
• Obesity and PCOS: Implications for Diagnosis and Treatment

  2012cites this paper
• Prevalence of hypothyroidism in infertile women and evaluation of response of treatment for hypothyroidism on infertility

  2012cites this paper
• Alopecia and Hirsuties

  2012cites this paper
• Reproductive Endocrinology and Related Disorders

  2012cites this paper
• Adrenocortical steroid response to ACTH in different phenotypes of non-obese polycystic ovary syndrome

  2012cites this paper
• Polycystic ovary syndrome: a dermatologic approach.

  2011cites this paper
• Síndrome do ovário policístico: abordagem dermatológica

  2011cites this paper
• Polycystic Ovary Syndrome

  2010cites this paper
• Optimización de los protocolos de hiperestimulación ovárica controlada para FIV/ICSI en pacientes diagnosticadas de síndrome de ovarios poliquísticos

  2010cites this paper
• Hirsutism

  2009cites this paper
• Polycystic Ovary Syndrome GJ.qxp

  2009cites this paper
• For information on reprint requests of more than 101 and commercial reprints contact

  2008cites this paper
• Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline.

  2008cites this paper
• Title: Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline Short Title: Guidelines for Treatment of Women with Hirsutism

  2008cites this paper
• Pathogenesis of Hyperandrogenism in Polycystic Ovary Syndrome

  2008cites this paper
• Title: Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline Short Title: Guidelines for Treatment of Women with Hirsutism

  2008cites this paper
• Polycystic ovary syndrome

  2007cites this paper
• The adrenal and polycystic ovary syndrome

  2007cites this paper
• Serum levels of 3α-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects

  2007cites this paper
• Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity.

  2007cites this paper
• Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.

  2007cites this paper
• CAPN10 UCSNP-43, UCSNP-19 and UCSNP-63 polymorphisms and metabolic syndrome in polycystic ovary syndrome

  2007cites this paper
• Hypothalamic-Pituitary-Adrenal Dysfunction in the Polycystic Ovary Syndrome

  2006cites this paper
• Insulin resistance and the polycystic ovary syndrome

  2005cites this paper
• Clinical diagnosis of hirsutism in Thai women.

  2004cites this paper
• Intermittent low-dose finasteride is as effective as daily administration for the treatment of hirsute women.

  2004cites this paper
• Serum levels of prostate-specific antigen and androgens after nasal administration of a gonadotropin releasing hormone-agonist in hirsute women

  2004cites this paper
• Clinical and metabolic findings in adolescent females with hyperandrogenism.

  2004cites this paper
• Paracoccidioidomycosis in a Woman with Idiopathic Hirsutism

  2004cites this paper
• Functioning ovarian tumors: direct and indirect findings at MR imaging.

  2004cites this paper
• Diagnostic Criteria in Polycystic Ovary Syndrome

  2003cites this paper
• What are the key features of importance in polycystic ovary syndrome?

  2003cites this paper
• Insulin-lowering agents in the management of polycystic ovary syndrome.

  2003cites this paper
• Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans.

  2003cites this paper
• Polycystic Ovarian Syndrome

  2003cites this paper
• The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals.

  2003cites this paper
• Gene expression of type 2 17β hydroxysteroid dehydrogenase in scalp hairs of hirsute women

  2003cites this paper
• The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome.

  2002cites this paper
• The 5 alpha-reductase type 1 , but not type 2 , gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals

  2002cites this paper
• A highly specific heterologous enzyme immunoassay for 5 alpha-androstane-3 alpha, 17 beta-diol 17-glucuronide (androstanediol-17G) and developmental patterns of urinary androstanediol-17G excretions.

  2002cites this paper
• Andrógenos e SHBG: Em Busca do Elo Desconhecido

  2002cites this paper
• Aspectos Genéticos del Síndrome de Ovario Poliquístico Genetic Aspects of Polycystic Ovary Syndrome

  2002cites this paper
• Polycystic ovary syndrome: the new millenium

  2001cites this paper
• Current concepts in the polycystic ovary syndrome.

  2001cites this paper
• Terapia dell’androgenizzazione cutanea nella donna

  2001cites this paper
• Hyperandrogenemia in patients presenting with acne.

  2001cites this paper
• CURRENT C ONCEPTS IN THE P OLYCYSTIC OVARY SYNDROME

  2001cites this paper
• Insulin resistance in polycystic ovary syndrome: hyperandrogenemia versus normoandrogenemia.

  2001cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2001cites this paper
• A Risk-Benefit Assessment of Pharmacological Therapies for Hirsutism

  2001cites this paper
• Idiopathic hirsutism.

  2000cites this paper
• Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome.

  2000cites this paper
• The Importance of Diagnosing the Polycystic Ovary Syndrome

  2000cites this paper
• Insulin Sensitizers and Antiandrogens in the Treatment of Polycystic Ovary Syndrome

  2000cites this paper
• Cardiovascular consequences of polycystic ovary syndrome.

  1999cites this paper
• Finasteride for hirsutism: a dose finding study.

  1998cites this paper
• How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?

  1998cites this paper
• Serum levels of 3alpha-androstanediol glucuronide in hirsute and non hirsute women.

  1998cites this paper
• The obstetrician-gynecologist's role in the practical management of polycystic ovary syndrome.

  1998cites this paper
• Phenotype and genotype in polycystic ovary syndrome.

  1998cites this paper
• Stellen 5 α-Androstan-3 α, 17 β-diol und 5 α-Androstan-3 α-diol-glukuronid biochemische Marker bei Hirsutismus dar? Eine Untersuchung mittels Gaschromatographie- Massenspektrometrie*

  1997cites this paper
• Diagnosis and therapy of hyperandrogenism.

  1997cites this paper
• Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

  1997cites this paper
• Androgen UDP-glucuronyl transferase activity is found primarily in the liver in the human.

  1997cites this paper
• 9 Diagnosis and therapy of hyperandrogenism

  1997cites this paper
• Insulin Resistance in the Polycystic Ovary Syndrome

  1996cites this paper
• The concentration of GnRH in hypothalamus, LH and FSH in pituitary, LH, PRL and sex steroids in peripheral and ovarian venous plasma of hypo- and hyperthyroid, cysts-bearing gilts.

  1996cites this paper
• Antiandrogen and hormonal treatment of acne.

  1996cites this paper
• Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.

  1996cites this paper
• Finasteride in the treatment of hirsutism: new therapeutic perspectives.

  1996cites this paper
• Finasteride in the treatment of hirsutism: new therapeutic perspectives.

  1996cites this paper
• A simple, differential extraction method for the simultaneous direct radioimmunoassay of androgens and androgen glucuronides in human serum.

  1996cites this paper
• ANTIANDROGEN THERAPY IN DERMATOLOGY

  1996cites this paper
• A contribution to the classification of cases of non-classic 21-hydroxylase-deficient congenital adrenal hyperplasia.

  1995cites this paper
• Substrate dependency of C19 conjugates in hirsute hyperandrogenic women and the influence of adrenal androgen.

  1995cites this paper
• Metabolism of dihydrotestosterone to 5 alpha-androstane-3 alpha, 17 beta-diol glucuronide is greater in the peripheral compartment than in the splanchnic compartment.

  1995cites this paper
• Clinical relevance of testosterone and dihydrotestosterone metabolism in women.

  1995cites this paper